A carregar...
A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial
INTRODUCTION: To assess satisfaction and quality of life in patients with relapsing–remitting multiple sclerosis (RRMS) who were receiving fingolimod (0.5 mg/day) for 12 months as a second-line treatment after switching from injectable agents. METHODS: Patients aged 18–65 years with RRMS who fulfill...
Na minha lista:
| Publicado no: | Noro Psikiyatr Ars |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Noro-Psikiyatri Arsivi
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6927087/ https://ncbi.nlm.nih.gov/pubmed/31903032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/npa.2017.20515 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|